Content
All Posts > Content under Healthcare
Parexel To Be Acquired By Pamplona In Transaction Valued At Approximately $5B
Article By:
The Fly
Read
Tuesday, June 20, 2017 8:34 AM EDT
Parexel International Corporation and Pamplona Capital Management announced that they have entered into a definitive agreement under which Pamplona will acquire all of the outstanding shares of Parexel for $88.10 per share in cash.
In this article: PRXL
The Top 4 Trading Assets Of The Week - Monday, June 19
Article By:
Anyoption
Read
Monday, June 19, 2017 11:51 PM EDT
Overall, the Fed’s activities should be bullish for the USD, but they appear to be bearish. More importantly, the interest-rate hikes have had the opposite effect on gold bullion, causing the precious metal to rise, rather than to fall.
In this article: BAC, FXC, GLD, UUP Also: TVX, AXP, BNO, C, CAT, CVX, JNJ, MS, NKE, WFC, WMT, XOM, BABA
ETF Watchlist: Week Of June 19, 2017
Article By:
David Dierking
Read
Sunday, June 18, 2017 4:35 PM EDT
The broader S&P 500 (SPY) was largely unchanged for the week but there were winners and losers if you dug down to the sector level. For the second straight week, tech was a drag on the market.
Health Care Battle Rages On: Two MedTech Stocks To Buy
Article By:
Zacks Investment Research
Read
Saturday, June 17, 2017 7:59 PM EDT
If Obamacare replacement takes place, there is a huge possibility that the Medical Device fraternity will be free from the highly unpopular Cadillac tax (40% excise tax on high-cost healthcare plans) and the controversial 2.3% MedTech tax.
Medtronic: Why Investors Should Expect This Dividend Aristocrat To Raise Its Dividend Again Soon
Article By:
SureDividend
Read
Saturday, June 17, 2017 12:54 PM EDT
Healthcare giant Medtronic, has raised its dividend for an impressive 39 years in a row. Even better, the company has raised its dividend by an average rate of nearly 20% annually, over the course of those 39 years.
In this article: MDT
AstraZeneca: 4% Dividend Yield And A Pipeline To Emerging Market Growth
Article By:
SureDividend
Read
Thursday, June 15, 2017 11:35 AM EDT
AstraZeneca’s strong pipeline and heavy presence in the emerging markets lay the groundwork for future growth.
Alnylam (ALNY) Stock To Maintain Momentum With New Patent Win
Article By:
KKD Healthcare Analytics
Read
Thursday, June 15, 2017 9:18 AM EDT
Alnylam Pharmaceuticals Inc. boosted its patent portfolio with new allowances from USPTO as the regulatory authority issued the notices with regard to the patent application.
In this article: ALNY
India Globalization Capital's FY'17 Earnings Breakdown
Article By:
The Daily Marijuana Observer
Read
Wednesday, June 14, 2017 7:00 PM EDT
Results reflect a steep cut in expenses associated with the company's renewed focus on its cannabinoid therapy development portfolio.
In this article: IGC
Premarket Biotech Digest – RDHL Initiates Two Products. BMY Starts Recall, PULM Inks New Deal
Article By:
KKD Healthcare Analytics
Read
Wednesday, June 14, 2017 9:07 AM EDT
RedHill Biopharma stock perked up as the company announced starting two GI-focused products in the U.S. Aptose Biosciences stock is on rally as the company announced updates for its pipeline candidates CG'806 and APTO-253.
Look At Fidelity Select Health Care Services Portfolio (FSHCX)
Article By:
Zacks Investment Research
Read
Wednesday, June 14, 2017 7:30 AM EDT
Fidelity Select Health Care Services Portfolio normally invests at least 80% of assets in common stocks of companies principally engaged in the ownership or management of hospitals, nursing homes, and health maintenance organizations.
In this article: FSHCX